Literature DB >> 23088564

Distress, sexual dysfunctions, and DSM: dialogue at cross purposes?

Lies Hendrickx1, Luk Gijs, Paul Enzlin.   

Abstract

INTRODUCTION: A distress criterion was added to the diagnostic criteria of sexual dysfunctions in Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV; 1994). This decision was neither based on empirical evidence, nor on an open, academic, or public debate about its necessity. As a result, this decision has been disputed ever since the publication of DSM-IV. AIM: In this article, the necessity to include or exclude the distress criterion from the diagnostic criteria of sexual dysfunctions is critically evaluated, illustrating its consequences for both sex research and clinical practice.
METHODS: Apart from careful reading of relevant sections in DSM-II, DSM-III, DSM-IV, DSM-IV Text Revision, and articles about and online proposals for DSM-5, an extensive PubMed literature search was performed including words as "sexual dysfunction"/"sexual difficulty"/"sexual disorder,""distress"/"clinical significance,""diagnostic criteria," and "DSM"/"Diagnostic and statistical manual of mental disorders." Based on analysis of the references of the retrieved works, more relevant articles were also found. MAIN OUTCOME MEASURES: ARGUMENTS for or against removal of distress from the diagnostic criteria of sexual dysfunctions by former and current members of the DSM Task Force and Work Group on Sexual Disorders, as well as by other authors in the field of sex research, are reviewed and critically assessed.
RESULTS: Proponents and opponents of including the distress criterion in the diagnostic criteria of sexual dysfunctions appear to be unresponsive to each others' arguments. To prevent the debate from becoming an endlessly repetitive discussion, it is first necessary to acknowledge that this is a philosophical debate about the nature, function, and goals of the diagnosis of a sexual dysfunction.
CONCLUSIONS: Given the current lack of data supporting either the retention or removal of the distress criterion, distress should always be taken into account in future research on sexual dysfunctions. Such forthcoming data should increase our understanding of the association between distress and sexual difficulties.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 23088564     DOI: 10.1111/j.1743-6109.2012.02971.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  Prevalence and correlates of sexual morbidity in long-term breast cancer survivors.

Authors:  Greer A Raggio; Meghan L Butryn; Danielle Arigo; Renee Mikorski; Steven C Palmer
Journal:  Psychol Health       Date:  2014-01-28

Review 2.  Defining psychosis: the evolution of DSM-5 schizophrenia spectrum disorders.

Authors:  Mahendra T Bhati
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

3.  Sexual dysfunction among youth: an overlooked sexual health concern.

Authors:  Caroline Moreau; Anna E Kågesten; Robert Wm Blum
Journal:  BMC Public Health       Date:  2016-11-18       Impact factor: 3.295

4.  Efficacy of Internet-Based Guided Treatment for Genito-Pelvic Pain/Penetration Disorder: Rationale, Treatment Protocol, and Design of a Randomized Controlled Trial.

Authors:  Anna-Carlotta Zarski; Matthias Berking; David Daniel Ebert
Journal:  Front Psychiatry       Date:  2018-01-22       Impact factor: 4.157

Review 5.  The Tenuous Role of Distress in the Diagnosis of Premature Ejaculation: A Narrative Review.

Authors:  David L Rowland; Stewart E Cooper
Journal:  Sex Med       Date:  2022-07-26       Impact factor: 2.523

6.  Estimating the Prevalence of Sexual Function Problems: The Impact of Morbidity Criteria.

Authors:  Kirstin R Mitchell; Kyle G Jones; Kaye Wellings; Anne M Johnson; Cynthia A Graham; Jessica Datta; Andrew J Copas; John Bancroft; Pam Sonnenberg; Wendy Macdowall; Nigel Field; Catherine H Mercer
Journal:  J Sex Res       Date:  2015-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.